ProCE Banner Activity

Why I Favor Treatments That Prevent Recurrence of Clostridioides Difficile Infection

Clinical Thought

I think appropriate treatment of initial infection is our best opportunity to avoid the cycle of recurrent CDI—and now the guidelines agree.

Released: February 11, 2022

Expiration: February 10, 2023

No longer available for credit.

Share

Faculty

Paul Feuerstadt

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine
Attending Gastroenterologist
Department of Gastroenterology
Yale University School of Medicine
PACT-Gastroenterology Center
Hamden, Connecticut

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine
Attending Gastroenterologist
Department of Gastroenterology
Yale University School of Medicine
PACT-Gastroenterology Center
Hamden, Connecticut

Paul Feuerstadt, MD, FACG, AGAF, has disclosed that he has received funds for speakers bureau participation from Ferring, Merck, and Takeda; consulting fees from Ferring; and funds for advisory board participation from Ferring and Takeda.